129 related articles for article (PubMed ID: 34904521)
1. Co-delivery of F7 and crizotinib by thermosensitive liposome for breast cancer treatment.
Li M; Li Y; Li S; Jia L; Du C; Li M; Li S; Galons H; Guo N; Yu P
J Liposome Res; 2022 Sep; 32(3):265-275. PubMed ID: 34904521
[TBL] [Abstract][Full Text] [Related]
2. F7 and topotecan co-loaded thermosensitive liposome as a nano-drug delivery system for tumor hyperthermia.
Du C; Li S; Li Y; Galons H; Guo N; Teng Y; Zhang Y; Li M; Yu P
Drug Deliv; 2020 Dec; 27(1):836-847. PubMed ID: 32508162
[TBL] [Abstract][Full Text] [Related]
3. Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.
Li M; Li Z; Yang Y; Wang Z; Yang Z; Li B; Xie X; Song J; Zhang H; Li Y; Gao G; Yang J; Mei X; Gong W
Pharm Res; 2016 Aug; 33(8):1881-98. PubMed ID: 27075873
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of doxorubicin delivery by a CO2 generating liposomal platform in breast carcinoma.
Han HD; Jeon YW; Kwon HJ; Jeon HN; Byeon Y; Lee CO; Cho SH; Shin BC
Acta Biomater; 2015 Sep; 24():279-285. PubMed ID: 26102337
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
[TBL] [Abstract][Full Text] [Related]
6. Cationic liposomes co-deliver chemotherapeutics and siRNA for the treatment of breast cancer.
Li M; Li S; Li Y; Li X; Yang G; Li M; Xie Y; Su W; Wu J; Jia L; Li S; Ma W; Li H; Guo N; Yu P
Eur J Med Chem; 2022 Apr; 233():114198. PubMed ID: 35245829
[TBL] [Abstract][Full Text] [Related]
7. Concomitant delivery of doxorubicin and cisplatin through liposome-based thermosensitive nanoparticles: perspective in the treatment of cancer in animal models.
Maswadeh HM; Khan A; Alorainy MS; Al-Wabel NA; Demetzos C
Am J Cancer Res; 2023; 13(2):379-393. PubMed ID: 36895979
[TBL] [Abstract][Full Text] [Related]
8. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
9. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
10. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
11. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and efficacy of thermosensitive liposomes containing paclitaxel.
Wang ZY; Zhang H; Yang Y; Xie XY; Yang YF; Li Z; Li Y; Gong W; Yu FL; Yang Z; Li MY; Mei XG
Drug Deliv; 2016 May; 23(4):1222-31. PubMed ID: 26666408
[TBL] [Abstract][Full Text] [Related]
13. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
14. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
[TBL] [Abstract][Full Text] [Related]
15. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model.
Gasselhuber A; Dreher MR; Rattay F; Wood BJ; Haemmerich D
PLoS One; 2012; 7(10):e47453. PubMed ID: 23082168
[TBL] [Abstract][Full Text] [Related]
16. EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery.
Haeri A; Zalba S; Ten Hagen TL; Dadashzadeh S; Koning GA
Colloids Surf B Biointerfaces; 2016 Oct; 146():657-69. PubMed ID: 27434152
[TBL] [Abstract][Full Text] [Related]
17. Gold cluster-labeled thermosensitive liposmes enhance triggered drug release in the tumor microenvironment by a photothermal effect.
Kwon HJ; Byeon Y; Jeon HN; Cho SH; Han HD; Shin BC
J Control Release; 2015 Oct; 216():132-9. PubMed ID: 26247553
[TBL] [Abstract][Full Text] [Related]
18. Review of the Delivery Kinetics of Thermosensitive Liposomes.
Haemmerich D; Ramajayam KK; Newton DA
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672347
[TBL] [Abstract][Full Text] [Related]
19. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
20. Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy.
Rezaeian M; Sedaghatkish A; Soltani M
Drug Deliv; 2019 Dec; 26(1):898-917. PubMed ID: 31526065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
